Royce & Associates LP Makes New Investment in Alpha Teknova, Inc. $TKNO

Royce & Associates LP purchased a new stake in shares of Alpha Teknova, Inc. (NASDAQ:TKNO) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 293,576 shares of the company’s stock, valued at approximately $1,116,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Alpha Teknova during the second quarter valued at about $29,000. ProShare Advisors LLC acquired a new position in Alpha Teknova during the fourth quarter worth about $38,000. JPMorgan Chase & Co. raised its position in Alpha Teknova by 123.1% in the second quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock worth $40,000 after acquiring an additional 4,504 shares in the last quarter. Larson Financial Group LLC lifted its holdings in Alpha Teknova by 58.5% in the 3rd quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after acquiring an additional 3,464 shares during the last quarter. Finally, Sherbrooke Park Advisers LLC acquired a new position in shares of Alpha Teknova in the 3rd quarter worth approximately $94,000. Institutional investors own 13.81% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Alpha Teknova in a research note on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $8.00.

Alpha Teknova Price Performance

TKNO stock opened at $5.40 on Monday. Alpha Teknova, Inc. has a one year low of $1.91 and a one year high of $6.68. The firm has a 50-day moving average of $3.35 and a two-hundred day moving average of $3.44. The firm has a market capitalization of $289.49 million, a PE ratio of -16.88 and a beta of 0.62. The company has a current ratio of 4.59, a quick ratio of 3.60 and a debt-to-equity ratio of 0.20.

Alpha Teknova (NASDAQ:TKNO) last released its earnings results on Wednesday, May 6th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01. The business had revenue of $11.08 million for the quarter, compared to the consensus estimate of $10.23 million. Alpha Teknova had a negative net margin of 41.07% and a negative return on equity of 24.32%.

Insiders Place Their Bets

In other news, CEO Stephen Gunstream acquired 26,000 shares of the stock in a transaction on Friday, March 6th. The shares were purchased at an average cost of $2.15 per share, for a total transaction of $55,900.00. Following the transaction, the chief executive officer owned 269,497 shares in the company, valued at approximately $579,418.55. This trade represents a 10.68% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 12.50% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.